Scienture Holdings Inc. (SCNX)
SCNX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.24
-17.14% on the day
Market cap
$5.3M
Nano cap
Revenue · 2025
$432K
+215.9% on 2024
Net income · 2025
-$41.5M
-9618.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | SCNX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001382574 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $432K |
| Net income | -$41.5M |
| Operating income | -$42.6M |
| Net margin | -9618.0% |
| Operating margin | -9867.9% |
| Revenue growth | +215.9% |
| Cash | $6.7M |
| Total assets | $84.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 12.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-11-07 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-10-07 |
| Latest proxy | DEF 14A | 2026-09-18 |
Source: SEC EDGAR submissions feed, 505 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GELS | Gelteq Limited | $0.4801 | -2.06% | $5.1M |
| ADXN | Addex Therapeutics Ltd | $3.01 | -0.99% | $5.1M |
| PULM | Pulmatrix Inc. | $1.38 | -3.50% | $5.0M |
| KALA | KALA BIO Inc. | $0.2600 | -7.14% | $5.0M |
| PCSA | Processa Pharmaceuticals Inc. | $1.77 | -6.84% | $5.0M |
| XBIO | Xenetic Biosciences Inc. | $2.10 | -0.94% | $4.9M |
| XTLB | XTL Biopharmaceuticals Ltd. | $1.98 | +3.12% | $4.9M |
| MDCX | Medicus Pharma Ltd. Common Stock | $3.28 | -8.38% | $5.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier